GRI Bio, Inc. (GRI) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.19M | -18.3% |
| 2024 | -$8.61M | +4.2% |
| 2023 | -$8.99M | -728.6% |
| 2022 | -$1.08M | +86.9% |
| 2021 | -$8.31M | -124.3% |
| 2020 | -$3.71M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$10.19M | -18.3% |
| 2024 | -$8.61M | +4.2% |
| 2023 | -$8.99M | -728.6% |
| 2022 | -$1.08M | +86.9% |
| 2021 | -$8.31M | -124.3% |
| 2020 | -$3.71M | — |